Sanofi to accelerate European COVID-19 vaccine access after CEO prioritizes U.S. preorders

spike

FILE PHOTO: The logo of Sanofi is seen at the company’s headquarters in Paris, France, April 24, 2020. REUTERS/Charles Platiau

NEW YORK (Reuters) – French drugmaker Sanofi SA said on Wednesday that it is working with European regulators to speed up access to a potential coronavirus vaccine in Europe after its chief executive suggested Americans would likely get the vaccine first.

The company said in a statement that it is currently in talks with the European Union and the French and German governments to expedite regional vaccine development.

Sanofi, whose Pasteur division has an established track record of producing influenza

Read More